Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia

<br><strong>Background: </strong>Primaquine (PQ) prevents relapses of vivax malaria but may induce severe haemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient patients. Data on the safety of primaquine in infants are limited.</br> <br><strong>Methods:...

Full description

Bibliographic Details
Main Authors:	Setyadi, A, Arguni, E, Kenangalem, E, Hasanuddin, A, Lampah, DA, Thriemer, K, Anstey, NM, Sugiarto, P, Simpson, JA, Price, RN, Douglas, NM, Poespoprodjo, JR
Format:	Journal article
Language:	English
Published:	BioMed Central 2019

Similar Items

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
by: Thriemer, K, et al.
Published: (2020)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
by: Douglas, NM, et al.
Published: (2017)

High risk of Plasmodium vivax malaria following splenectomy in Papua, Indonesia
by: Kho, S, et al.
Published: (2018)

Expanding the use of primaquine for the radical cure of Plasmodium vivax
by: Price, RN, et al.
Published: (2018)

Early and late mortality after malaria in young children in Papua, Indonesia
by: Patriani, D, et al.
Published: (2019)

Malaria-related hospitalization during childhood in Papua, Indonesia: A retrospective cohort study
by: Douglas, NM, et al.
Published: (2020)

Mortality attributable to Plasmodium vivax malaria: a clinical audit from Papua, Indonesia.
by: Douglas, N, et al.
Published: (2014)

Plasmodium vivax infection: a major determinant of severe anaemia in infancy
by: Kenangalem, E, et al.
Published: (2017)

Coma associated with microscopy-diagnosed Plasmodium vivax: a prospective study in Papua, Indonesia
by: Lampah, D, et al.
Published: (2011)

Plasmodium vivax infection: A major determinant of severe anaemia in Papua, Indonesia
by: Price, R, et al.
Published: (2007)

Primaquine for plasmodium vivax malaria treatment – authors' reply
by: Price, RN, et al.
Published: (2020)

Severe disease associated with both Plasmodium falciparum and P-vivax infection in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2007)

Adherence to radical cure for Plasmodium vivax malaria in Papua, Indonesia
by: Rahmalia, A, et al.
Published: (2019)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: A prospective study in Papua, Indonesia
by: Tjitra, E, et al.
Published: (2008)

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia.
by: Tjitra, E, et al.
Published: (2008)

Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial
by: Poespoprodjo, JR, et al.
Published: (2021)

The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study
by: Dini, S, et al.
Published: (2020)

Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.
by: Poespoprodjo, JR, et al.
Published: (2008)

Vivax malaria: a major cause of morbidity in early infancy.
by: Poespoprodjo, JR, et al.
Published: (2009)

Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study.
by: Douglas, N, et al.
Published: (2013)

Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum.
by: Karyana, M, et al.
Published: (2008)

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
by: Yilma, D, et al.
Published: (2023)

Greater endothelial activation, Weibel-Palade body release and host inflammatory response to Plasmodium vivax, compared with Plasmodium falciparum: a prospective study in Papua, Indonesia.
by: Yeo, T, et al.
Published: (2010)

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study
by: Rahmalia, A, et al.
Published: (2023)

Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: a rising burden of Plasmodium vivax malaria
by: Poespoprodjo, JR, et al.
Published: (2019)

MULTIDRUG RESISTANT VIVAX MALARIA: A MAJOR CAUSE OF MORBIDITY IN EARLY LIFE
by: Poespoprodjo, JR, et al.
Published: (2008)

Characterization of blood dendritic and regulatory T cells in asymptomatic adults with sub-microscopic Plasmodium falciparum or Plasmodium vivax infection.
by: Kho, S, et al.
Published: (2016)

Loss of complement regulatory proteins on uninfected erythrocytes in vivax and falciparum malaria anemia
by: Oyong, DA, et al.
Published: (2018)

Treatment seeking behavior of patients with Plasmodium falciparum or P-vivax infection in Papua, Indonesia
by: Karyana, M, et al.
Published: (2007)

Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy
by: Poespoprodjo, JR, et al.
Published: (2014)

Risk of Plasmodium vivax parasitaemia after Plasmodium falciparum infection: a systematic review and meta-analysis
by: Commons, RJ, et al.
Published: (2018)

Treatment-seeking behavior after the implementation of a unified policy of dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua, Indonesia
by: Devine, A, et al.
Published: (2017)

Severe malarial thrombocytopenia: a risk factor for mortality in Papua, Indonesia.
by: Lampah, D, et al.
Published: (2015)

Plasmodium vivax: clinical spectrum, risk factors and pathogenesis.
by: Anstey, N, et al.
Published: (2012)

Plasmodium malariae infection associated with a high burden of anemia: a hospital-based surveillance study
by: Langford, S, et al.
Published: (2015)

Increased circulating myeloid-derived suppressor cells in vivax malaria and severe falciparum malaria
by: Leonardo, L, et al.
Published: (2022)

The anaemia of Plasmodium vivax malaria.
by: Douglas, N, et al.
Published: (2012)

Treatment of primaquine-resistant Plasmodium vivax malaria.
by: Luzzi, G, et al.
Published: (1992)

TREATMENT OF PRIMAQUINE-RESISTANT PLASMODIUM-VIVAX MALARIA
by: Luzzi, G, et al.
Published: (1992)

Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia
by: Pava, Z, et al.
Published: (2020)